Physician profile
Nathan Rendler
NPI 1275531337
$1,123.69
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.86 · 2020: $64.23 · 2021: $71.94 · 2022: $93.41 · 2023: $122 · 2024: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $519.38 | 2021-2024 | Qelbree |
| Kaleo, INC. | $295.75 | 2019-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $84.00 | 2022-2024 | Vaxneuvance, M-M-R II, Gardasil 9 |
| Pfizer INC. | $83.48 | 2020-2024 | |
| Sanofi Pasteur INC. | $47.25 | 2022-2024 | |
| Cranial Technologies, INC | $29.35 | 2019 | |
| Seqirus USA INC | $28.88 | 2021-2022 | |
| Glaxosmithkline, LLC. | $21.00 | 2024 | Bexsero, Rotarix |
| Astrazeneca Pharmaceuticals LP | $14.60 | 2023 | Evusheld |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Rendler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.